Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCH CD3-OLS)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
51 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Calgary
Calgary, Alberta, Canada
- Edmonton
Edmonton, Alberta, Canada
- Vancouver
Vancouver, British Columbia, Canada
- Victoria
Victoria, British Columbia, Canada
- Moncton
Moncton, New Brunswick, Canada
- Phoenix
Phoenix, Arizona, United States
- North Little Rock
North Little Rock, Arkansas, United States
- Oxnard
Oxnard, California, United States
- Aurora
Aurora, Colorado, United States
- Hamden
Hamden, Connecticut, United States
- Gainesville
Gainesville, Florida, United States
- Jacksonville
Jacksonville, Florida, United States
- Naples
Naples, Florida, United States
- Orlando
Orlando, Florida, United States
- Port Orange
Port Orange, Florida, United States
- Atlanta
Atlanta, Georgia, United States
- Decatur
Decatur, Georgia, United States
- Idaho Falls
Idaho Falls, Idaho, United States
- Burr Ridge
Burr Ridge, Illinois, United States
- Gurnee
Gurnee, Illinois, United States
- Fort Wayne
Fort Wayne, Indiana, United States
- Wichita
Wichita, Kansas, United States
- New Orleans
New Orleans, Louisiana, United States
- Shreveport
Shreveport, Louisiana, United States
- Baltimore
Baltimore, Maryland, United States
- Detroit
Detroit, Michigan, United States
- Plymouth
Plymouth, Minnesota, United States
- Rochester
Rochester, Minnesota, United States
- St. Louis
St Louis, Missouri, United States
- New York
New York, New York, United States
- Rochester
Rochester, New York, United States
- Durham
Durham, North Carolina, United States
- Fargo
Fargo, North Dakota, United States
- Cleveland
Cleveland, Ohio, United States
- Oklahoma City
Oklahoma City, Oklahoma, United States
- Philadelphia
Philadelphia, Pennsylvania, United States
- Pittsburgh
Pittsburgh, Pennsylvania, United States
- Wyomissing
Wyomissing, Pennsylvania, United States
- Charleston
Charleston, South Carolina, United States
- Hixon
Hixon, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jul 2019
- Primary completion
- 21 Jul 2023
- Completion
- 21 Jul 2023
- Last update posted
- 7 Aug 2024
- Registered enrollment
- 793
- Registry id
- NCT03931941
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.